These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Therapeutic education regarding type 1 diabetes (DM1)]. Jansà M; Vidal M; Conget I; Giménez M; Esmatjes E; Yoldi C; Levy I Rev Enferm; 2007 Oct; 30(10):23-32. PubMed ID: 18274393 [TBL] [Abstract][Full Text] [Related]
3. AADE position statement: education for continuous subcutaneous insulin infusion pump users. American Association of Diabetes Educators. Diabetes Educ; 1997; 23(4):397-8. PubMed ID: 9305004 [TBL] [Abstract][Full Text] [Related]
4. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion]. Szypowska A; Pańkowska E; Lipka M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861 [TBL] [Abstract][Full Text] [Related]
5. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery. Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974 [No Abstract] [Full Text] [Related]
6. Current status and future of implantable insulin pumps for the treatment of diabetes. Catargi B Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038 [TBL] [Abstract][Full Text] [Related]
7. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues. Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931 [TBL] [Abstract][Full Text] [Related]
9. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. Jarosz-Chobot P Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073 [TBL] [Abstract][Full Text] [Related]
12. Diabetics treated with continuous subcutaneous insulin infusion pumps. Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015 [TBL] [Abstract][Full Text] [Related]
13. Type I diabetes and insulin therapy. Hirsch IB; Farkas-Hirsch R Nurs Clin North Am; 1993 Mar; 28(1):9-23. PubMed ID: 8451220 [TBL] [Abstract][Full Text] [Related]
14. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment]. Mozdzan M; Ruxer J; Loba J Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330 [TBL] [Abstract][Full Text] [Related]
15. Continuous insulin infusion systems in type 2 diabetes. Kesavadev J J Assoc Physicians India; 2011 Apr; 59 Suppl():41-3. PubMed ID: 21818997 [TBL] [Abstract][Full Text] [Related]
16. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Bode BW Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065 [TBL] [Abstract][Full Text] [Related]
17. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Eugster EA; Francis G; Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512 [TBL] [Abstract][Full Text] [Related]
20. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]